For example, it was reported that miR-133a repressed the mRNA and protein expression of FSCN1 in bladder cancer (26), as well as targeting the expression of FSCN1, and suppressing tumor cell invasion and migration in breast cancer (18). This evidence concerns the gene FSCN1 and breast cancer.